BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30574258)

  • 1. Evaluation of non-adherence to anti-retroviral therapy, the associated factors and infant outcomes among HIV-positive pregnant women: a prospective cohort study in Lesotho.
    Kadima N; Baldeh T; Thin K; Thabane L; Mbuagbaw L
    Pan Afr Med J; 2018; 30():239. PubMed ID: 30574258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-Month HIV-free survival among HIV-exposed Infants in Lesotho: the PEAWIL cohort study.
    Tukei VJ; Machekano R; Gill MM; Tiam A; Mokone M; Isavwa A; Nyabela M; Mots'oane T; Nchephe S; Letsie M; Kassaye SG; Guay L
    J Int AIDS Soc; 2020 Dec; 23(12):e25648. PubMed ID: 33314744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
    PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 6-week PMTCT outcomes for HIV-exposed and HIV-unexposed infants in the era of lifelong ART: Results from an observational prospective cohort study.
    Tiam A; Kassaye SG; Machekano R; Tukei V; Gill MM; Mokone M; Letsie M; Tsietso M; Seipati I; Barasa J; Isavwa A; Tylleskär T; Guay L
    PLoS One; 2019; 14(12):e0226339. PubMed ID: 31877153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa.
    Adeniyi OV; Ajayi AI; Ter Goon D; Owolabi EO; Eboh A; Lambert J
    BMC Infect Dis; 2018 Apr; 18(1):175. PubMed ID: 29653510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of mother-to-child transmission of HIV in pregnancy and among HIV-exposed infants accessing care at a PMTCT clinic in southwest Nigeria.
    Afolabi AY; Bakarey AS; Kolawole OE; Kola OJ
    J Immunoassay Immunochem; 2018; 39(4):403-415. PubMed ID: 30001188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda.
    Napyo A; Tylleskär T; Mukunya D; Tumuhamye J; Musaba MW; Ojok Arach AA; Waako P; Tumwine JK; Ndeezi G
    PLoS One; 2020; 15(10):e0240529. PubMed ID: 33057393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of adherence to option B+ approach for the prevention of mother to child transmission of human immunodeficiency virus in Abuja, 2017.
    Dada AO; Abubakar A; Bashorun A; Nguku P; Oladimeji A
    Pan Afr Med J; 2021; 38():54. PubMed ID: 33854683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to antiretroviral therapy among HIV infected pregnant women in public health sectors: a pilot of Chilenje level one Hospital Lusaka, Zambia.
    Mukosha M; Chiyesu G; Vwalika B
    Pan Afr Med J; 2020; 35():49. PubMed ID: 32537054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria.
    Rawizza HE; Chang CA; Chaplin B; Ahmed IA; Meloni ST; Oyebode T; Banigbe B; Sagay AS; Adewole IF; Okonkwo P; Kanki PJ;
    Curr HIV Res; 2015; 13(3):201-9. PubMed ID: 25986371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study.
    Mirkuzie AH; Hinderaker SG; Sisay MM; Moland KM; Mørkve O
    J Int AIDS Soc; 2011 Oct; 14():50. PubMed ID: 22017821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Mother-to-Child Transmission of HIV in Option B+ Era: Uptake and Adherence During Pregnancy in Western Uganda.
    Schnack A; Rempis E; Decker S; Braun V; Rubaihayo J; Busingye P; Tumwesigye NM; Harms G; Theuring S
    AIDS Patient Care STDS; 2016 Mar; 30(3):110-8. PubMed ID: 27308804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
    Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
    Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of antiretroviral therapy in HIV-positive women ever enrolled into 'prevention of mother to child transmission' programme, Mandalay, Myanmar-a cohort study.
    Kyaw KWY; Satyanarayana S; Phyo KH; Kyaw NTT; Mon AA; Lwin TT; Aung TK; Oo MM; Aung ZZ; Htun T; Kham NSN; Mya T; Kumar AMV; Oo HN
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):474. PubMed ID: 30514239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa.
    Larsen A; Magasana V; Dinh TH; Ngandu N; Lombard C; Cheyip M; Ayalew K; Chirinda W; Kindra G; Jackson D; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):789. PubMed ID: 31526366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.